Corgenix Medical Corporation (CONX) Announces Issuance of Additional U.S. Patent for AspirinWorks® (11-dehydro Thromboxane B2) Test

5/29/2012 10:11:55 AM

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks® technology.

Read at GlobeNewswire

Read Article at

Related Companies

News Categories

• GlobeNewswire

• Corgenix Medical Corporation

• Medical Devices

• Medical Dev. & Diag. - Patent News